Searched for
CLARIS NET PROFIT
Perfios acquires fraud detection platform Clari5Perfios acquired fraud detection platform Clari5 to enhance its fraud management capabilities. Clari5, with 200 employees, becomes a Perfio...
Baxter to acquire Claris Injectables for Rs 4,237 crore"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...
Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
Claris Lifesciences plunges 11% as company reports weak Q3 numbersShares of Claris Lifesciences plunged over 7 per cent in Monday's trade after the company reported net losses of Rs 69 crore for the Decemb...
Claris Lifesciences Q1 net up 31 per cent at Rs 20.28 croreDrug firm Claris Lifesciences today reported a 31.09 per cent rise in its consolidated net profit to Rs 20.28 crore for the quarter.
Thirteen stocks in focus in Tuesday's tradeIndian markets are expected to trade in a range. Here is a list of thirteen stocks which are likely to remain in focus today.
Claris Lifesciences January-March qtr net dips 22% to Rs 10 croreDrug firm Claris Lifesciences today reported a 21.73 decline in its consolidated net profit at Rs 10.44 crore for the quarter ended March 3...
Claris Life at record high on Q4 results, surges over 42% in two daysThe stock had rallied in previous session following reports that big national and international companies are in fray to buy company’s inje...
Claris Lifesciences Q4 net zooms five-fold at Rs 90 croreClaris Lifesciences reported an over five-fold jump in its consolidated net profit at Rs 89.84 crore for the quarter ended December 31, 210...
Claris Lifesciences' consolidated net profit at Rs 15.4 crore in June '14The company's net revenues for the quarter stood at Rs 151.05 crore as against Rs 202.20 crore in the same period last year.
Claris Lifesciences Q4 profit declines 29.50 per cent to Rs 17.75 croreClaris Lifesciences today reported a 29.50 per cent decline in consolidated net profit to Rs 17.75 crore for the quarter ended on December ...
Claris Lifesciences Q2 net profit falls 43.65 pc to Rs 18.2 crSterile injectables manufacturer Claris Lifesciences today reported a 43.65 per cent decline in net profit at Rs 18.2 crore for the second ...
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%
Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
Claris Lifesciences Q4 net dips 27 pc at Rs 25 croreClaris Lifesciences reported 27.28 pc decline in its consolidated net profit at Rs 25.18 crore for the fourth quarter ended December 31, 20...
- Claris Lifesciences Net Profit dips 27%, revenue down by 5%
Claris Lifesciences Ltd, net profit dips successive for second time in a year. The net profit for the third quarter dropped by 27.34% and r...
- Claris Lifesciences net profit falls 14%, USFDA clearance awaiting
The consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris Lifesciences yet to get USFDA clearance
Claris Lifesciences said its consolidated net profit rose 9% for the first quarter of calendar year 2012 to Rs 21.7 crore.
- Claris gets Russian nod for anti-infective drugs
Claris raised Rs 300 crore in December through its maiden IPO. On Thursday, its stock dipped 2.48% to close at Rs 161.40.
- Subscribe to Claris Lifesciences IPO: Angel Broking
Claris has grown at strong pace with net sales increasing at CAGR of 26.9% & net profit of 65.6%.
- Claris gets nod for Rs 300-crore IPO
Claris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.